Prosecution Insights
Last updated: April 19, 2026

Sanegene Bio Usa Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18650710 SMALL INTERFERING RNA TARGETING C3 AND USES THEREOF VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Apr 30, 2024
17960202 POLYHYDROXYLATED CYCLOPENTANE DERIVATIVES AND METHODS OF USE BRANDSEN, BENJAMIN MICHAEL 1693 Non-Final OA Oct 05, 2022
17950520 2'-ALKYL OR 3'- ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE SHIAO, YIH-HORNG 1691 Non-Final OA Sep 22, 2022

Managing Sanegene Bio Usa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month